Back to search

France· FR:62404505

BEYONTTRA 356 mg, comprimé pelliculé

A acoramidis product containing chlorhydrate d'acoramidis, registered in France by BAYER AG (ALLEMAGNE), on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C01EB25

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedBEYONTTRA 356 mg, comprimé pelliculéATCC01EB25REGISTER NO.FR:62404505PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Acoramidis is registered in 14 of 19 countries.

Countries holding a registration under ATC C01EB25 (acoramidis), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Acoramidis · ATC C01EB25

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acoramidis costs, country by country.

Normalised to the WHO defined daily dose (1.424 g), the median price runs from $0.17 in France to $300.19 in Switzerland — a ×1790 gap.

  • France: $0.17 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Acoramidis · price per daily dose (1.424 g)

USD · FX 28 Sept 2026

  • CH Switzerland$300.19
  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE D'ACORAMIDIS
Manufacturer
BAYER AG (ALLEMAGNE)
Country
France (FR)
ATC code
C01EB25
ATC class
Acoramidis
Defined daily dose
1.424 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930311066
    plaquette(s) PVC polychlortrifluoroéthylène aluminium de 120 comprimé(s)
    EUR 4.42

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acoramidis in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acoramidis products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Beyonttra
  • Liechtenstein · Beyonttra
  • Norway · Beyonttra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5dcd56d0-130b-406d-90c7-729894d51572
GET /v1/drugs/5dcd56d0-130b-406d-90c7-729894d51572?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62404505",
  "date_amm": "2025-02-10",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/24/1906",
  "substance": "CHLORHYDRATE D'ACORAMIDIS",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about acoramidis.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.